NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球瘧疾治療市場:2027年行業趨勢和預測

Global Malaria Treatment Market - Industry Trends and Forecast to 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 977321
出版日期 內容資訊 英文 447 Pages
商品交期: 3-5個工作天內
價格
全球瘧疾治療市場:2027年行業趨勢和預測 Global Malaria Treatment Market - Industry Trends and Forecast to 2027
出版日期: 2020年10月01日內容資訊: 英文 447 Pages
簡介

預計在2020年至2027年的預測期內,全球瘧疾治療市場將以6.1%的複合年增長率增長。

本報告研究了全球瘧疾治療市場,包括流行病學,市場機遇和挑戰,增長和限制因素,管道產品清單,調解/類型/治療類型/藥物類型/給藥途徑/目的。它提供的信息包括按用戶,分銷渠道和地區進行的市場分析,COVID-19的影響,競爭狀況以及主要公司的概況。

目錄

第1章簡介

第2章市場細分

第3章執行摘要

第4章流行病學

第5章管道分析

  • 管道產品清單

第6章規定

第7章市場概述

  • 生長因素
    • 政府指導和增加支出以預防瘧疾
    • 瘧疾的高患病率和疾病負擔
    • 醫療保險的興起
    • 非洲某些地區的潮濕氣候條件和蚊子(Gambie hamadaraka)
  • 抑制因素
    • 與抗瘧藥相關的副作用和風險
    • 缺乏與瘧疾症狀相關的意識
    • 經濟增長緩慢,醫療設施發展,無法獲得先進治療
  • 市場機會
    • 大型公司的聯盟和協議
    • 特色產品發佈
    • 增加羥基氯金和氯金的生產以及進出口
  • 挑戰
    • 抗瘧疾藥物審批的監管挑戰
    • 實現通用訪問

第8章COVID-19的影響

  • 對價格的影響
  • 對供應鏈的影響
  • 對需求的影響
  • 製造商的戰略決策
  • 結論

第9章市場分析:通過調解

  • 概述
  • 熱帶熱瘧原蟲
  • 新月瘧原蟲
  • 橢圓形瘧原蟲
  • 四日熱瘧原蟲
  • 瘧原蟲

第10章市場分析:按類型

  • 概述
  • 藥物
    • 氯黴素
    • Primakin
    • 基於青蒿素的聯合治療
    • 凱寧
    • 羥氯金
    • Mefrokin
    • 與非青蒿素鹼組合
    • 其他
  • 疫苗
    • RTS,S/AS01
    • PFSPZ
    • 其他

第11章市場分析:按治療類型

  • 概述
  • 抑制治療
  • 根治

第12章市場分析:按藥品類型

  • 概述
  • 通用
  • 品牌
    • ARTEFAN
    • COARTEM
    • RIAMET
    • MALARONE
    • EURARTESIM
    • LONART
    • 其他

第13章市場分析:按管理途徑

  • 概述
  • 口服
  • 局部
    • 點滴
    • 肌肉
    • 皮下

第14章市場分析:按最終用戶

  • 概述
  • 醫院
  • 專科診所
  • 醫療保健
  • 其他

第15章市場分析:按分銷渠道

  • 概述
  • 直接出價
  • 醫院藥房
  • 零售藥房
  • 在線藥房

第16章市場分析:按地區

  • 概述
  • 中東/非洲
    • 尼日利亞
    • 剛果民主共和國
    • 烏干達
    • 莫桑比克
    • 尼日爾
    • 科特迪瓦
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 埃及
    • 科威特
    • 其他
  • 亞太地區
    • 印度
    • 印度尼西亞
    • 韓國
    • 泰國
    • 菲律賓
    • 越南
    • 日本
    • 澳大利亞
    • 新加坡
    • 中國
    • 馬來西亞
    • 其他
  • 南美洲
    • 巴西
    • 秘魯
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 意大利
    • 英國
    • 西班牙
    • 荷蘭
    • 比利時
    • 俄羅斯
    • 瑞士
    • 奧地利
    • 愛爾蘭
    • 土耳其
    • 匈牙利
    • 立陶宛
    • 挪威
    • 波蘭
    • 其他
  • 北美
    • 美國
    • 墨西哥
    • 加拿大

第17章競爭情況

  • 企業份額分析:全球
  • 公司股份分析:中東/非洲
  • 企業份額分析:亞太地區
  • 企業份額分析:南美

第18章SWOT分析

第19章公司簡介

  • AJANTA PHARMA
  • NOVARTIS AG
  • CIPLA INC.
  • STRIDES PHARMA SCIENCE LIMITED
  • HIKMA PHARMACEUTICALS PLC
  • IPCA LABORATORIES LTD.
  • MYLAN N.V.
  • SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
  • ACTIZA PHARMACEUTICAL PRIVATE LIMITED
  • ADVACARE PHARMA
  • AMNEAL PHARMACEUTICALS LLC
  • BLISS GVS PHARMA LTD.
  • GEOVAX
  • LUPIN PHARMACEUTICALS, INC. (A SUBSIDIARY OF LUPIN)
  • MMV
  • OSIVAX
  • SUMAYA BIOTECH
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • TAJ PHARMACEUTICALS LIMITED
  • VLP THERAPEUTICS
  • ZYDUS CADILA

第20章調查表

第21章相關報告

目錄

Global malaria treatment market is projected to register a healthy CAGR of 6.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

Global Malaria Treatment Market, By Agent (Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae and P. Knowlelsi), Type (Medication and Vaccination), Treatment Type (Suppressive Treatment and Radical Treatment), Drug Type (Branded and Generics), Route of Administration (Oral and Parenteral) End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Nigeria, Democratic Republic of the Congo, Uganda, Mozambique, Niger, Cote d'Ivoire, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Kuwait and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the malaria treatment market are:

Growing awareness for malaria symptoms.

Humid climatic conditions and very efficient mosquito (anopheles gambiae complex) in certain parts of Africa.

Market Players

The key market players for the malaria treatment market are listed below:

Actiza Pharmaceutical Private Limited

AdvaCare Pharma

Amneal Pharmaceuticals LLC.

Hikma Pharmaceuticals PLC

Ipca Laboratories Ltd.

Mylan N.V.

Sun Pharmaceutical Industries Ltd.

Zydus Cadila

Cipla Inc.

Bliss GVS Pharma Ltd.

GeoVax

MMV

Novartis AG

Sumaya Biotech

Taj Pharmaceuticals Limited

VLP Therapeutics

OSIVAX

Lupin Pharmaceuticals, Inc. (a subsidiary of LUPIN)

AJANTA PHARMA

Strides Pharma Science Limited

sanofi-aventis U.S. LLC (a subsidiary of Sanofi)

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL MALARIA TREATMENT MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 MARKET TYPE COVERAGE GRID
  • 2.8 AGENT LIFELINE CURVE
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 EPIDEMIOLOGY

5 PIPELINE ANALYSIS

  • 5.1 LIST OF PIPELINE PRODUCTS

6 REGULATIONS

7 MARKET OVERVIEW

  • 7.1 DRIVERS
    • 7.1.1 INCREASE IN GOVERNMENT INITIATION AND EXPENDITURE FOR PREVENTION OF MALARIA
    • 7.1.2 HIGH PREVALENCE AND DISEASE BURDEN OF MALARIA
    • 7.1.3 RISE IN MEDICAL INSURANCE
    • 7.1.4 HUMID CLIMATIC CONDITIONS AND EFFICIENT MOSQUITO (ANOPHELES GAMBIAE COMPLEX) IN CERTAIN PARTS OF AFRICA
  • 7.2 RESTRAINTS
    • 7.2.1 ADVERSE EFFECTS AND RISKS ASSOCIATED WITH ANTI-MALARIA DRUGS
    • 7.2.2 LACK OF AWARENESS RELATED TO SYMPTOMS OF MALARIA
    • 7.2.3 LOW ECONOMIC GROWTH, UNDERDEVELOPED HEALTHCARE INFRASTRUCTURE, AND LACK OF ACCESS TO ADVANCED TREATMENT
  • 7.3 OPPORTUNITY
    • 7.3.1 PARTNERSHIP AND AGREEMENT BY MAJOR PLAYERS
    • 7.3.2 RISING PRODUCT LAUNCHES
    • 7.3.3 INCREASE IN THE PRODUCTION AND EXPORT AS WELL AS IMPORT OF HYDROXYCHLOROQUINE AND CHLOROQUINE
  • 7.4 CHALLENGES
    • 7.4.1 REGULATORY CHALLENGES TO ANTIMALARIAL DRUG APPROVAL
    • 7.4.2 ACHIEVING UNIVERSAL ACCESS

8 COVID-19 IMPACT ON MALARIA TREATMENT IN HEALTHCARE INDUSTRY

  • 8.1 PRICE IMPACT
  • 8.2 IMPACT ON SUPPLY CHAIN
  • 8.3 IMPACT ON DEMAND
  • 8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
  • 8.5 CONCLUSION

9 GLOBAL MALARIA TREATMENT MARKET, BY AGENT

  • 9.1 OVERVIEW
  • 9.2 PLASMODIUM FALCIPARUM
  • 9.3 P. VIVAX
  • 9.4 P. OVALE
  • 9.5 P. MALARIAE
  • 9.6 P. KNOWLELSI

10 GLOBAL MALARIA TREATMENT MARKET, BY TYPE

  • 10.1 OVERVIEW
  • 10.2 MEDICATION
    • 10.2.1 CHLOROQUINE
    • 10.2.2 PRIMAQUINE
    • 10.2.3 ARTEMISININ-BASED COMBINATION THERAPY (ACT)
      • 10.2.3.1 ARTEMETHER-LUMEFANTRINE
      • 10.2.3.2 ARTESUNATE-AMODIAQUINE
      • 10.2.3.3 DIHYDROARTEMISININ-PIPERAQUINE
      • 10.2.3.4 OTHERS
    • 10.2.4 QUININE
    • 10.2.5 HYDROXYCHLOROQUINE
    • 10.2.6 MEFLOQUINE
    • 10.2.7 NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS)
      • 10.2.7.1 SULFADOXINE-PYRIMETHAMINE WITH CHLOROQUINE
      • 10.2.7.2 SULFADOXINE-PYRIMETHAMINE WITH AMODIAQUINE
      • 10.2.7.3 OTHERS
    • 10.2.8 OTHERS
  • 10.3 VACCINE
    • 10.3.1 RTS,S/AS01
    • 10.3.2 PFSPZ
    • 10.3.3 OTHERS

11 GLOBAL MALARIA TREATMENT MARKET, BY TREATMENT TYPE

  • 11.1 OVERVIEW
  • 11.2 SUPPRESSIVE TREATMENT
  • 11.3 RADICAL TREATMENT

12 GLOBAL MALARIA TREATMENT MARKET, BY DRUG TYPE

  • 12.1 OVERVIEW
  • 12.2 GENERICS
  • 12.3 BRANDED
    • 12.3.1 ARTEFAN
    • 12.3.2 COARTEM
    • 12.3.3 RIAMET
    • 12.3.4 MALARONE
    • 12.3.5 EURARTESIM
    • 12.3.6 LONART
    • 12.3.7 OTHERS

13 GLOBAL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • 13.1 OVERVIEW
  • 13.2 ORAL
  • 13.3 PARENTERAL
    • 13.3.1 INTRAVENOUS
    • 13.3.2 INTRAMUSCULAR
    • 13.3.3 SUBCUTANEOUS

14 GLOBAL MALARIA TREATMENT MARKET, BY END USER

  • 14.1 OVERVIEW
  • 14.2 HOSPITALS
  • 14.3 SPECIALTY CLINICS
  • 14.4 HOME HEALTHCARE
  • 14.5 OTHERS

15 GLOBAL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • 15.1 OVERVIEW
  • 15.2 DIRECT TENDER
  • 15.3 HOSPITAL PHARMACIES
  • 15.4 RETAIL PHARMACIES
  • 15.5 ONLINE PHARMACIES

16 GLOBAL MALARIA TREATMENT MARKET, BY GEOGRAPHY

  • 16.1 OVERVIEW
  • 16.2 MIDDLE EAST & AFRICA
    • 16.2.1 NIGERIA
    • 16.2.2 DEMOCRATIC REPUBLIC OF THE CONGO
    • 16.2.3 UGANDA
    • 16.2.4 MOZAMBIQUE
    • 16.2.5 NIGER
    • 16.2.6 COTE D'IVOIRE
    • 16.2.7 SOUTH AFRICA
    • 16.2.8 SAUDI ARABIA
    • 16.2.9 UAE
    • 16.2.10 ISRAEL
    • 16.2.11 EGYPT
    • 16.2.12 KUWAIT
    • 16.2.13 REST OF MIDDLE EAST & AFRICA
  • 16.3 ASIA-PACIFIC
    • 16.3.1 INDIA
    • 16.3.2 INDONESIA
    • 16.3.3 SOUTH KOREA
    • 16.3.4 THAILAND
    • 16.3.5 PHILIPPINES
    • 16.3.6 VIETNAM
    • 16.3.7 JAPAN
    • 16.3.8 AUSTRALIA
    • 16.3.9 SINGAPORE
    • 16.3.10 CHINA
    • 16.3.11 MALAYSIA
    • 16.3.12 REST OF ASIA-PACIFIC
  • 16.4 SOUTH AMERICA MALARIA TREATMENT MARKET, BY COUNTRY
    • 16.4.1 BRAZIL
    • 16.4.2 PERU
    • 16.4.3 ARGENTINA
    • 16.4.4 REST OF SOUTH AMERICA
  • 16.5 EUROPE
    • 16.5.1 GERMANY
    • 16.5.2 FRANCE
    • 16.5.3 ITALY
    • 16.5.4 U.K
    • 16.5.5 SPAIN
    • 16.5.6 NETHERLANDS
    • 16.5.7 BELGIUM
    • 16.5.8 RUSSIA
    • 16.5.9 SWITZERLAND
    • 16.5.10 AUSTRIA
    • 16.5.11 IRELAND
    • 16.5.12 TURKEY
    • 16.5.13 HUNGARY
    • 16.5.14 LITHUANIA
    • 16.5.15 NORWAY
    • 16.5.16 POLAND
    • 16.5.17 REST OF EUROPE
  • 16.6 NORTH AMERICA
    • 16.6.1 U.S.
    • 16.6.2 MEXICO
    • 16.6.3 CANADA

17 GLOBAL MALARIA TREATMENT MARKET: COMPANY LANDSCAPE

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 17.2 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
  • 17.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
  • 17.4 COMPANY SHARE ANALYSIS: SOUTH AMERICA

18 SWOT ANALYSIS

19 COMPANY PROFILE

  • 19.1 AJANTA PHARMA
    • 19.1.1 COMPANY SNAPSHOT
    • 19.1.2 REVENUE ANALYSIS
    • 19.1.3 COMPANY SHARE ANALYSIS
    • 19.1.4 PRODUCT PORTFOLIO
    • 19.1.5 RECENT DEVELOPMENTS
  • 19.2 NOVARTIS AG
    • 19.2.1 COMPANY SNAPSHOT
    • 19.2.2 REVENUE ANALYSIS
    • 19.2.3 COMPANY SHARE ANALYSIS
    • 19.2.4 PRODUCT PORTFOLIO
    • 19.2.5 RECENT DEVELOPMENTS
  • 19.3 CIPLA INC.
    • 19.3.1 COMPANY SNAPSHOT
    • 19.3.2 REVENUE ANALYSIS
    • 19.3.3 COMPANY SHARE ANALYSIS
    • 19.3.4 PRODUCT PORTFOLIO
    • 19.3.5 RECENT DEVELOPMENTS
  • 19.4 STRIDES PHARMA SCIENCE LIMITED
    • 19.4.1 COMPANY SNAPSHOT
    • 19.4.2 REVENUE ANALYSIS
    • 19.4.3 COMPANY SHARE ANALYSIS
    • 19.4.4 PRODUCT PORTFOLIO
    • 19.4.5 RECENT DEVELOPMENT
  • 19.5 HIKMA PHARMACEUTICALS PLC
    • 19.5.1 COMPANY SNAPSHOT
    • 19.5.2 REVENUE ANALYSIS
    • 19.5.3 COMPANY SHARE ANALYSIS
    • 19.5.4 PRODUCT PORTFOLIO
    • 19.5.5 RECENT DEVELOPMENTS
  • 19.6 IPCA LABORATORIES LTD.
    • 19.6.1 COMPANY SNAPSHOT
    • 19.6.2 REVENUE ANALYSIS
    • 19.6.3 PRODUCT PORTFOLIO
    • 19.6.4 RECENT DEVELOPMENTS
  • 19.7 MYLAN N.V.
    • 19.7.1 COMPANY SNAPSHOT
    • 19.7.2 REVENUE ANALYSIS
    • 19.7.3 PRODUCT PORTFOLIO
    • 19.7.4 RECENT DEVELOPMENTS
  • 19.8 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
    • 19.8.1 COMPANY SNAPSHOT
    • 19.8.2 REVENUE ANALYSIS
    • 19.8.3 PRODUCT PORTFOLIO
    • 19.8.4 RECENT DEVELOPMENTS
  • 19.9 ACTIZA PHARMACEUTICAL PRIVATE LIMITED
    • 19.9.1 COMPANY SNAPSHOT
    • 19.9.2 PRODUCT PORTFOLIO
    • 19.9.3 RECENT DEVELOPMENT
  • 19.10 ADVACARE PHARMA
    • 19.10.1 COMPANY SNAPSHOT
    • 19.10.2 PRODUCT PORTFOLIO
    • 19.10.3 RECENT DEVELOPMENT
  • 19.11 AMNEAL PHARMACEUTICALS LLC
    • 19.11.1 COMPANY SNAPSHOT
    • 19.11.2 REVENUE ANALYSIS
    • 19.11.3 PRODUCT PORTFOLIO
    • 19.11.4 RECENT DEVELOPMENTS
  • 19.12 BLISS GVS PHARMA LTD.
    • 19.12.1 COMPANY SNAPSHOT
    • 19.12.2 REVENUE ANALYSIS
    • 19.12.3 PRODUCT PORTFOLIO
    • 19.12.4 RECENT DEVELOPMENTS
  • 19.13 GEOVAX
    • 19.13.1 COMPANY SNAPSHOT
    • 19.13.2 REVENUE ANALYSIS
    • 19.13.3 PRODUCT PORTFOLIO
    • 19.13.4 RECENT DEVELOPMENT
  • 19.14 LUPIN PHARMACEUTICALS, INC. (A SUBSIDIARY OF LUPIN)
    • 19.14.1 COMPANY SNAPSHOT
    • 19.14.2 REVENUE ANALYSIS
    • 19.14.3 PRODUCT PORTFOLIO
    • 19.14.4 RECENT DEVELOPMENTS
  • 19.15 MMV
    • 19.15.1 COMPANY SNAPSHOT
    • 19.15.2 REVENUE ANALYSIS
    • 19.15.3 PRODUCT PORTFOLIO
    • 19.15.4 RECENT DEVELOPMENTS
  • 19.16 OSIVAX
    • 19.16.1 COMPANY SNAPSHOT
    • 19.16.2 PRODUCT PORTFOLIO
    • 19.16.3 RECENT DEVELOPMENT
  • 19.17 SUMAYA BIOTECH
    • 19.17.1 COMPANY SNAPSHOT
    • 19.17.2 PRODUCT PORTFOLIO
    • 19.17.3 RECENT DEVELOPMENT
  • 19.18 SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 19.18.1 COMPANY SNAPSHOT
    • 19.18.2 REVENUE ANALYSIS
    • 19.18.3 PRODUCT PORTFOLIO
    • 19.18.4 RECENT DEVELOPMENTS
  • 19.19 TAJ PHARMACEUTICALS LIMITED
    • 19.19.1 COMPANY SNAPSHOT
    • 19.19.2 PRODUCT PORTFOLIO
    • 19.19.3 RECENT DEVELOPMENT
  • 19.20 VLP THERAPEUTICS
    • 19.20.1 COMPANY SNAPSHOT
    • 19.20.2 PRODUCT PORTFOLIO
    • 19.20.3 RECENT DEVELOPMENTS
  • 19.21 ZYDUS CADILA
    • 19.21.1 COMPANY SNAPSHOT
    • 19.21.2 REVENUE ANALYSIS
    • 19.21.3 PRODUCT PORTFOLIO
    • 19.21.4 RECENT DEVELOPMENTS

20 QUESTIONNAIRE

21 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 GLOBAL MALARIA TREATMENT MARKET, PIPELINE ANALYSIS
  • TABLE 2 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED
  • TABLE 3 ESTIMATED MALARIA CASES AND DEATHS BY REGION, 2
  • TABLE 4 FUTURE VECTOR CARE - FUTURE GENERALI (MALARIA CARE FAMILY HEALTH PLAN)
  • TABLE 5 REGULATORY CHALLENGES TO ANTIMALARIAL DRUG APPROVAL
  • TABLE 6 CHALLENGES AND PROBLEMS THAT DRIVE THE R&D FRAMEWORK
  • TABLE 7 GLOBAL MALARIA TREATMENT MARKET, BY AGENT 2019-2027 (USD THOUSAND)
  • TABLE 8 GLOBAL PLASMODIUM FALCIPARUM IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)
  • TABLE 9 GLOBAL P. VIVAX IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)
  • TABLE 10 GLOBAL P. OVALE IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)
  • TABLE 11 GLOBAL P. MALARIAE IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)
  • TABLE 12 GLOBAL P. KNOWLELSI IN MALARIA TREATMENT MARKET, BY MONTH 2018-2027 (USD THOUSAND)
  • TABLE 13 GLOBAL MALARIA TREATMENT MARKET, BY TYPE 2019-2027 (USD THOUSAND)
  • TABLE 14 GLOBAL MEDICATION IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)
  • TABLE 15 GLOBAL MEDICATION IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 16 GLOBAL ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 17 GLOBAL NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 18 GLOBAL VACCINE IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)
  • TABLE 19 GLOBAL VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 20 GLOBAL MALARIA TREATMENT MARKET, BY TREATMENT TYPE 2019-2027 (USD THOUSAND)
  • TABLE 21 GLOBAL SUPPRESSIVE TREATMENT IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 22 GLOBAL RADICAL TREATMENT IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 23 GLOBAL MALARIA TREATMENT MARKET, BY DRUG TYPE 2019-2027 (USD THOUSAND)
  • TABLE 24 GLOBAL GENERICS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 25 GLOBAL BRANDED IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 26 GLOBAL BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 27 GLOBAL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2019-2027 (USD THOUSAND)
  • TABLE 28 GLOBAL ORAL IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 29 GLOBAL PARENTERAL IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 30 GLOBAL PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 31 GLOBAL MALARIA TREATMENT MARKET, BY END USER 2019-2027 (USD THOUSAND)
  • TABLE 32 GLOBAL HOSPITALS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 33 GLOBAL SPECIALTY CLINICS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 34 GLOBAL HOME HEALTHCARE IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 35 GLOBAL OTHERS IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 36 GLOBAL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2027 (USD THOUSAND)
  • TABLE 37 GLOBAL DIRECT TENDER IN MALARIA TREATMENT MARKET, BY REGION, 2017-2027 (USD THOUSAND)
  • TABLE 38 GLOBAL HOSPITAL PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 39 GLOBAL RETAIL PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 40 GLOBAL ONLINE PHARMACIES IN MALARIA TREATMENT MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 41 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)
  • TABLE 42 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 43 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 44 MIDDLE EAST & AFRICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 45 MIDDLE EAST & AFRICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 46 MIDDLE EAST & AFRICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 47 MIDDLE EAST & AFRICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 48 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 49 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 50 MIDDLE EAST & AFRICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 51 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 52 MIDDLE EAST & AFRICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 53 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 54 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 55 NIGERIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 56 NIGERIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 57 NIGERIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 58 NIGERIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 59 NIGERIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 60 NIGERIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 61 NIGERIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 62 NIGERIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 63 NIGERIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 64 NIGERIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 65 NIGERIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 66 NIGERIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 67 NIGERIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 68 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 69 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 70 DEMOCRATIC REPUBLIC OF THE CONGO MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 71 DEMOCRATIC REPUBLIC OF THE CONGO ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 72 DEMOCRATIC REPUBLIC OF THE CONGO NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 73 DEMOCRATIC REPUBLIC OF THE CONGO VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 74 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 75 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 76 DEMOCRATIC REPUBLIC OF THE CONGO BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 77 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 78 DEMOCRATIC REPUBLIC OF THE CONGO PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 79 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 80 DEMOCRATIC REPUBLIC OF THE CONGO MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 81 UGANDA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 82 UGANDA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 83 UGANDA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 84 UGANDA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 85 UGANDA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 86 UGANDA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 87 UGANDA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 88 UGANDA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 89 UGANDA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 90 UGANDA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 91 UGANDA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 92 UGANDA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 93 UGANDA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 94 MOZAMBIQUE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 95 MOZAMBIQUE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 96 MOZAMBIQUE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 97 MOZAMBIQUE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 98 MOZAMBIQUE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 99 MOZAMBIQUE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 100 MOZAMBIQUE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 101 MOZAMBIQUE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 102 MOZAMBIQUE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 103 MOZAMBIQUE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 104 MOZAMBIQUE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 105 MOZAMBIQUE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 106 MOZAMBIQUE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 107 NIGER MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 108 NIGER MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 109 NIGER MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 110 NIGER ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 111 NIGER NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 112 NIGER VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 113 NIGER MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 114 NIGER MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 115 NIGER BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 116 NIGER MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 117 NIGER PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 118 NIGER MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 119 NIGER MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 120 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 121 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 122 CÔTE D'IVOIRE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 123 CÔTE D'IVOIRE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 124 CÔTE D'IVOIRE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 125 CÔTE D'IVOIRE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 126 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 127 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 128 CÔTE D'IVOIRE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 129 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 130 CÔTE D'IVOIRE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 131 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 132 CÔTE D'IVOIRE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 133 SOUTH AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 134 SOUTH AFRICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 135 SOUTH AFRICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 136 SOUTH AFRICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 137 SOUTH AFRICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 138 SOUTH AFRICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 139 SOUTH AFRICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 140 SOUTH AFRICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 141 SOUTH AFRICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 142 SOUTH AFRICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 143 SOUTH AFRICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 144 SOUTH AFRICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 145 SOUTH AFRICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 146 SAUDI ARABIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 147 SAUDI ARABIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 148 SAUDI ARABIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 149 SAUDI ARABIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 150 SAUDI ARABIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 151 SAUDI ARABIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 152 SAUDI ARABIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 153 SAUDI ARABIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 154 SAUDI ARABIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 155 SAUDI ARABIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 156 SAUDI ARABIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 157 SAUDI ARABIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 158 SAUDI ARABIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 159 UAE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 160 UAE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 161 UAE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 162 UAE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 163 UAE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 164 UAE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 165 UAE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 166 UAE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 167 UAE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 168 UAE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 169 UAE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 170 UAE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 171 UAE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 172 ISRAEL MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 173 ISRAEL MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 174 ISRAEL MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 175 ISRAEL ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 176 ISRAEL NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 177 ISRAEL VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 178 ISRAEL MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 179 ISRAEL MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 180 ISRAEL BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 181 ISRAEL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 182 ISRAEL PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 183 ISRAEL MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 184 ISRAEL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 185 EGYPT MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 186 EGYPT MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 187 EGYPT MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 188 EGYPT ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 189 EGYPT NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 190 EGYPT VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 191 EGYPT MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 192 EGYPT MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 193 EGYPT BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 194 EGYPT MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 195 EGYPT PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 196 EGYPT MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 197 EGYPT MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 198 KUWAIT MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 199 KUWAIT MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 200 KUWAIT MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 201 KUWAIT ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 202 KUWAIT NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 203 KUWAIT VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 204 KUWAIT MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 205 KUWAIT MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 206 KUWAIT BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 207 KUWAIT MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 208 KUWAIT PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 209 KUWAIT MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 210 KUWAIT MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 211 REST OF MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 212 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)
  • TABLE 213 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 214 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 215 ASIA-PACIFIC MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 216 ASIA-PACIFIC ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 217 ASIA-PACIFIC NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 218 ASIA-PACIFIC VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 219 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 220 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 221 ASIA-PACIFIC BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 222 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 223 ASIA-PACIFIC PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 224 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 225 ASIA-PACIFIC MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 226 INDIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 227 INDIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 228 INDIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 229 INDIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 230 INDIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 231 INDIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 232 INDIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 233 INDIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 234 INDIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 235 INDIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 236 INDIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 237 INDIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 238 INDIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 239 INDONESIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 240 INDONESIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 241 INDONESIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 242 INDONESIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 243 INDONESIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 244 INDONESIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 245 INDONESIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 246 INDONESIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 247 INDONESIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 248 INDONESIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 249 INDONESIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 250 INDONESIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 251 INDONESIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 252 SOUTH KOREA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 253 SOUTH KOREA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 254 SOUTH KOREA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 255 SOUTH KOREA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 256 SOUTH KOREA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 257 SOUTH KOREA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 258 SOUTH KOREA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 259 SOUTH KOREA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 260 SOUTH KOREA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 261 SOUTH KOREA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 262 SOUTH KOREA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 263 SOUTH KOREA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 264 SOUTH KOREA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 265 THAILAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 266 THAILAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 267 THAILAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 268 THAILAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 269 THAILAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 270 THAILAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 271 THAILAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 272 THAILAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 273 THAILAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 274 THAILAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 275 THAILAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 276 THAILAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 277 THAILAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 278 PHILIPPINES MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 279 PHILIPPINES MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 280 PHILIPPINES MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 281 PHILIPPINES ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 282 PHILIPPINES NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 283 PHILIPPINES VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 284 PHILIPPINES MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 285 PHILIPPINES MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 286 PHILIPPINES BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 287 PHILIPPINES MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 288 PHILIPPINES PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 289 PHILIPPINES MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 290 PHILIPPINES MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 291 VIETNAM MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 292 VIETNAM MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 293 VIETNAM MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 294 VIETNAM ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 295 VIETNAM NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 296 VIETNAM VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 297 VIETNAM MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 298 VIETNAM MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 299 VIETNAM BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 300 VIETNAM MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 301 VIETNAM PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 302 VIETNAM MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 303 VIETNAM MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 304 JAPAN MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 305 JAPAN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 306 JAPAN MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 307 JAPAN ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 308 JAPAN NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 309 JAPAN VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 310 JAPAN MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 311 JAPAN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 312 JAPAN BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 313 JAPAN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 314 JAPAN PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 315 JAPAN MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 316 JAPAN MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 317 AUSTRALIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 318 AUSTRALIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 319 AUSTRALIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 320 AUSTRALIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 321 AUSTRALIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 322 AUSTRALIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 323 AUSTRALIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 324 AUSTRALIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 325 AUSTRALIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 326 AUSTRALIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 327 AUSTRALIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 328 AUSTRALIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 329 AUSTRALIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 330 SINGAPORE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 331 SINGAPORE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 332 SINGAPORE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 333 SINGAPORE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 334 SINGAPORE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 335 SINGAPORE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 336 SINGAPORE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 337 SINGAPORE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 338 SINGAPORE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 339 SINGAPORE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 340 SINGAPORE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 341 SINGAPORE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 342 SINGAPORE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 343 CHINA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 344 CHINA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 345 CHINA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 346 CHINA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 347 CHINA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 348 CHINA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 349 CHINA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 350 CHINA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 351 CHINA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 352 CHINA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 353 CHINA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 354 CHINA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 355 CHINA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 356 MALAYSIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 357 MALAYSIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 358 MALAYSIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 359 MALAYSIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 360 MALAYSIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 361 MALAYSIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 362 MALAYSIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 363 MALAYSIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 364 MALAYSIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 365 MALAYSIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 366 MALAYSIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 367 MALAYSIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 368 MALAYSIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 369 REST OF ASIA-PACIFIC MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 370 SOUTH AMERICA MALARIA TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 371 SOUTH AMERICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 372 SOUTH AMERICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 373 SOUTH AMERICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 374 SOUTH AMERICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 375 SOUTH AMERICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 376 SOUTH AMERICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 377 SOUTH AMERICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 378 SOUTH AMERICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 379 SOUTH AMERICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 380 SOUTH AMERICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 381 SOUTH AMERICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 382 SOUTH AMERICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 383 SOUTH AMERICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 384 BRAZIL MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 385 BRAZIL MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 386 BRAZIL MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 387 BRAZIL ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 388 BRAZIL NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 389 BRAZIL VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 390 BRAZIL MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 391 BRAZIL MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 392 BRAZIL BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 393 BRAZIL MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 394 BRAZIL PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 395 BRAZIL MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 396 BRAZIL MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 397 PERU MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 398 PERU MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 399 PERU MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 400 PERU ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 401 PERU NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 402 PERU VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 403 PERU MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 404 PERU MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 405 PERU BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 406 PERU MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 407 PERU PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 408 PERU MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 409 PERU MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 410 ARGENTINA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 411 ARGENTINA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 412 ARGENTINA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 413 ARGENTINA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 414 ARGENTINA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 415 ARGENTINA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 416 ARGENTINA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 417 ARGENTINA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 418 ARGENTINA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 419 ARGENTINA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 420 ARGENTINA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 421 ARGENTINA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 422 ARGENTINA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 423 REST OF SOUTH AMERICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 424 EUROPE MALARIA TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 425 EUROPE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 426 EUROPE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 427 EUROPE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 428 EUROPE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 429 EUROPE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 430 EUROPE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 431 EUROPE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 432 EUROPE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 433 EUROPE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 434 EUROPE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 435 EUROPE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 436 EUROPE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 437 EUROPE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 438 GERMANY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 439 GERMANY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 440 GERMANY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 441 GERMANY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 442 GERMANY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 443 GERMANY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 444 GERMANY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 445 GERMANY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 446 GERMANY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 447 GERMANY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 448 GERMANY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 449 GERMANY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 450 GERMANY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 451 FRANCE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 452 FRANCE MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 453 FRANCE MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 454 FRANCE ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 455 FRANCE NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 456 FRANCE VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 457 FRANCE MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 458 FRANCE MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 459 FRANCE BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 460 FRANCE MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 461 FRANCE PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 462 FRANCE MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 463 FRANCE MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 464 ITALY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 465 ITALY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 466 ITALY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 467 ITALY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 468 ITALY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 469 ITALY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 470 ITALY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 471 ITALY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 472 ITALY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 473 ITALY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 474 ITALY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 475 ITALY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 476 ITALY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 477 U.K. MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 478 U.K. MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 479 U.K. MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 480 U.K. ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 481 U.K. NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 482 U.K. VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 483 U.K. MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 484 U.K. MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 485 U.K. BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 486 U.K. MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 487 U.K. PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 488 U.K. MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 489 U.K. MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 490 SPAIN MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 491 SPAIN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 492 SPAIN MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 493 SPAIN ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 494 SPAIN NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 495 SPAIN VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 496 SPAIN MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 497 SPAIN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 498 SPAIN BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 499 SPAIN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 500 SPAIN PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 501 SPAIN MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 502 SPAIN MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 503 NETHERLANDS MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 504 NETHERLANDS MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 505 NETHERLANDS MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 506 NETHERLANDS ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 507 NETHERLANDS NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 508 NETHERLANDS VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 509 NETHERLANDS MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 510 NETHERLANDS MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 511 NETHERLANDS BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 512 NETHERLANDS MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 513 NETHERLANDS PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 514 NETHERLANDS MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 515 NETHERLANDS MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 516 BELGIUM MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 517 BELGIUM MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 518 BELGIUM MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 519 BELGIUM ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 520 BELGIUM NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 521 BELGIUM VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 522 BELGIUM MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 523 BELGIUM MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 524 BELGIUM BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 525 BELGIUM MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 526 BELGIUM PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 527 BELGIUM MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 528 BELGIUM MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 529 RUSSIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 530 RUSSIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 531 RUSSIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 532 RUSSIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 533 RUSSIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 534 RUSSIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 535 RUSSIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 536 RUSSIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 537 RUSSIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 538 RUSSIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 539 RUSSIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 540 RUSSIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 541 RUSSIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 542 SWITZERLAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 543 SWITZERLAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 544 SWITZERLAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 545 SWITZERLAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 546 SWITZERLAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 547 SWITZERLAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 548 SWITZERLAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 549 SWITZERLAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 550 SWITZERLAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 551 SWITZERLAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 552 SWITZERLAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 553 SWITZERLAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 554 SWITZERLAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 555 AUSTRIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 556 AUSTRIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 557 AUSTRIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 558 AUSTRIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 559 AUSTRIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 560 AUSTRIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 561 AUSTRIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 562 AUSTRIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 563 AUSTRIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 564 AUSTRIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 565 AUSTRIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 566 AUSTRIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 567 AUSTRIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 568 IRELAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 569 IRELAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 570 IRELAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 571 IRELAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 572 IRELAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 573 IRELAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 574 IRELAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 575 IRELAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 576 IRELAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 577 IRELAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 578 IRELAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 579 IRELAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 580 IRELAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 581 TURKEY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 582 TURKEY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 583 TURKEY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 584 TURKEY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 585 TURKEY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 586 TURKEY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 587 TURKEY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 588 TURKEY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 589 TURKEY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 590 TURKEY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 591 TURKEY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 592 TURKEY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 593 TURKEY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 594 HUNGARY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 595 HUNGARY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 596 HUNGARY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 597 HUNGARY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 598 HUNGARY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 599 HUNGARY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 600 HUNGARY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 601 HUNGARY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 602 HUNGARY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 603 HUNGARY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 604 HUNGARY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 605 HUNGARY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 606 HUNGARY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 607 LITHUANIA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 608 LITHUANIA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 609 LITHUANIA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 610 LITHUANIA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 611 LITHUANIA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 612 LITHUANIA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 613 LITHUANIA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 614 LITHUANIA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 615 LITHUANIA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 616 LITHUANIA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 617 LITHUANIA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 618 LITHUANIA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 619 LITHUANIA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 620 NORWAY MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 621 NORWAY MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 622 NORWAY MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 623 NORWAY ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 624 NORWAY NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 625 NORWAY VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 626 NORWAY MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 627 NORWAY MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 628 NORWAY BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 629 NORWAY MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 630 NORWAY PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 631 NORWAY MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 632 NORWAY MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 633 POLAND MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 634 POLAND MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 635 POLAND MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 636 POLAND ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 637 POLAND NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 638 POLAND VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 639 POLAND MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 640 POLAND MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 641 POLAND BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 642 POLAND MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 643 POLAND PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 644 POLAND MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 645 POLAND MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 646 REST OF EUROPE MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 647 NORTH AMERICA MALARIA TREATMENT MARKET, BY REGION 2018-2027 (USD THOUSAND)
  • TABLE 648 NORTH AMERICA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 649 NORTH AMERICA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 650 NORTH AMERICA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 651 NORTH AMERICA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 652 NORTH AMERICA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 653 NORTH AMERICA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 654 NORTH AMERICA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 655 NORTH AMERICA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 656 NORTH AMERICA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 657 NORTH AMERICA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 658 NORTH AMERICA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 659 NORTH AMERICA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 660 NORTH AMERICA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 661 U.S. MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 662 U.S. MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 663 U.S. MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 664 U.S. ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 665 U.S. NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 666 U.S. VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 667 U.S. MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 668 U.S. MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 669 U.S. BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 670 U.S. MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 671 U.S. PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 672 U.S. MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 673 U.S. MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 674 MEXICO MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 675 MEXICO MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 676 MEXICO MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 677 MEXICO ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 678 MEXICO NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 679 MEXICO VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 680 MEXICO MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 681 MEXICO MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 682 MEXICO BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 683 MEXICO MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 684 MEXICO PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 685 MEXICO MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 686 MEXICO MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)
  • TABLE 687 CANADA MALARIA TREATMENT MARKET, BY AGENT, 2018-2027 (USD THOUSAND)
  • TABLE 688 CANADA MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 689 CANADA MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 690 CANADA ARTEMISININ-BASED COMBINATION THERAPY (ACT) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 691 CANADA NON-ARTEMISININ BASED COMBINATIONS (NON-ACTS) MEDICATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 692 CANADA VACCINATION IN MALARIA TREATMENT MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 693 CANADA MALARIA TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 694 CANADA MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 695 CANADA BRANDED IN MALARIA TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 696 CANADA MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 697 CANADA PARENTERAL IN MALARIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD THOUSAND)
  • TABLE 698 CANADA MALARIA TREATMENT MARKET, BY END USER 2018-2027 (USD THOUSAND)
  • TABLE 699 CANADA MALARIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD THOUSAND)

LIST OF FIGURES

  • FIGURE 1 GLOBAL MALARIA TREATMENT MARKET: SEGMENTATION 54
  • FIGURE 2 GLOBAL MALARIA TREATMENT MARKET: DATA TRIANGULATION 57
  • FIGURE 3 GLOBAL MALARIA TREATMENT MARKET: DROC ANALYSIS 58
  • FIGURE 4 GLOBAL MALARIA TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 59
  • FIGURE 5 GLOBAL MALARIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS 59
  • FIGURE 6 GLOBAL MALARIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS 60
  • FIGURE 7 GLOBAL MALARIA TREATMENT MARKET: MARKET TYPE COVERAGE GRID 62
  • FIGURE 8 GLOBAL MALARIA TREATMENT MARKET: DBMR MARKET POSITION GRID 64
  • FIGURE 9 GLOBAL MALARIA TREATMENT MARKET: VENDOR SHARE ANALYSIS 66
  • FIGURE 10 GLOBAL MALARIA TREATMENT MARKET: SEGMENTATION 70
  • FIGURE 11 MIDDLE EAST AND AFRICA IS ANTICIPATED TO DOMINATE THE GLOBAL MALARIA TREATMENT MARKET GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 71
  • FIGURE 12 INCREASE IN GOVERNMENT INITIATION AND EXPENDITURE FOR PREVENTION OF MALARIA IS EXPECTED TO DRIVE THE GLOBAL MALARIA TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 72
  • FIGURE 13 MEDICATION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MALARIA TREATMENT MARKET IN 2020 & 2027 72
  • FIGURE 14 MIDDLE EAST AND AFRICA IS THE FASTEST GROWING REGION FOR MALARIA TREATMENT MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027 73
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL MALARIA TREATMENT MARKET 83
  • FIGURE 16 THE U.S. FUNDING FOR GLOBAL MALARIA, FY 2001 -2021 85
  • FIGURE 17 MALARIA CASES IN THE 10 HIGHEST BURDEN COUNTRIES IN AFRICA, 2010-2017 88
  • FIGURE 18 GLOBAL MALARIA TREATMENT MARKET: BY AGENT, 2019 100
  • FIGURE 19 GLOBAL MALARIA TREATMENT MARKET: BY AGENT, 2019-2027 (USD THOUSAND) 101
  • FIGURE 20 GLOBAL MALARIA TREATMENT MARKET: BY AGENT, CAGR (2020-2027) 101
  • FIGURE 21 GLOBAL MALARIA TREATMENT MARKET: BY AGENT, LIFELINE CURVE 102
  • FIGURE 22 GLOBAL MALARIA TREATMENT MARKET: BY TYPE, 2019 109
  • FIGURE 23 GLOBAL MALARIA TREATMENT MARKET: BY TYPE, 2019-2027 (USD THOUSAND) 110
  • FIGURE 24 GLOBAL MALARIA TREATMENT MARKET: BY TYPE, CAGR (2020-2027) 110
  • FIGURE 25 GLOBAL MALARIA TREATMENT MARKET: BY TYPE, LIFELINE CURVE 111
  • FIGURE 26 GLOBAL MALARIA TREATMENT MARKET: BY TREATMENT TYPE, 2019 119
  • FIGURE 27 GLOBAL MALARIA TREATMENT MARKET: BY TREATMENT TYPE, 2019-2027 (USD THOUSAND) 120
  • FIGURE 28 GLOBAL MALARIA TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2020-2027) 120
  • FIGURE 29 GLOBAL MALARIA TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE 121
  • FIGURE 30 GLOBAL MALARIA TREATMENT MARKET: BY DRUG TYPE, 2019 125
  • FIGURE 31 GLOBAL MALARIA TREATMENT MARKET: BY DRUG TYPE, 2019-2027 (USD THOUSAND) 126
  • FIGURE 32 GLOBAL MALARIA TREATMENT MARKET: BY DRUG TYPE, CAGR (2020-2027) 126
  • FIGURE 33 GLOBAL MALARIA TREATMENT MARKET: BY DRUG TYPE, LIFELINE CURVE 127
  • FIGURE 34 GLOBAL MALARIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2019 133
  • FIGURE 35 GLOBAL MALARIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2019-2027 (USD THOUSAND) 134
  • FIGURE 36 GLOBAL MALARIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2027) 134
  • FIGURE 37 GLOBAL MALARIA TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE 135
  • FIGURE 38 GLOBAL MALARIA TREATMENT MARKET: BY END USER, 2019 140
  • FIGURE 39 GLOBAL MALARIA TREATMENT MARKET: BY END USER, 2019-2027 (USD THOUSAND) 141
  • FIGURE 40 GLOBAL MALARIA TREATMENT MARKET: BY END USER, CAGR (2020-2027) 141
  • FIGURE 41 GLOBAL MALARIA TREATMENT MARKET: BY END USER, LIFELINE CURVE 142
  • FIGURE 42 GLOBAL MALARIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019 148
  • FIGURE 43 GLOBAL MALARIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD THOUSAND) 149
  • FIGURE 44 GLOBAL MALARIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 149
  • FIGURE 45 GLOBAL MALARIA TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 150
  • FIGURE 46 GLOBAL MALARIA TREATMENT MARKET: SNAPSHOT (2019) 157
  • FIGURE 47 GLOBAL MALARIA TREATMENT MARKET: BY COUNTRY (2019) 159
  • FIGURE 48 GLOBAL MALARIA TREATMENT MARKET: BY COUNTRY (2020 & 2027) 159
  • FIGURE 49 GLOBAL MALARIA TREATMENT MARKET: BY COUNTRY (2019 & 2027) 160
  • FIGURE 50 GLOBAL MALARIA TREATMENT MARKET: BY TYPE (2020-2027) 160
  • FIGURE 51 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET: SNAPSHOT (2019) 162
  • FIGURE 52 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET: BY COUNTRY (2019) 164
  • FIGURE 53 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET: BY COUNTRY (2020 & 2027) 164
  • FIGURE 54 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET: BY COUNTRY (2019 & 2027) 165
  • FIGURE 55 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET: BY TYPE (2020-2027) 165
  • FIGURE 56 ASIA-PACIFIC MALARIA TREATMENT MARKET: SNAPSHOT (2019) 220
  • FIGURE 57 ASIA-PACIFIC MALARIA TREATMENT MARKET: BY COUNTRY (2019) 222
  • FIGURE 58 ASIA-PACIFIC MALARIA TREATMENT MARKET: BY COUNTRY (2020 & 2027) 222
  • FIGURE 59 ASIA-PACIFIC MALARIA TREATMENT MARKET: BY COUNTRY (2019 & 2027) 223
  • FIGURE 60 ASIA-PACIFIC MALARIA TREATMENT MARKET: BY TYPE (2020-2027) 223
  • FIGURE 61 SOUTH AMERICA MALARIA TREATMENT MARKET: SNAPSHOT (2019) 273
  • FIGURE 62 SOUTH AMERICA MALARIA TREATMENT MARKET: BY COUNTRY (2019) 275
  • FIGURE 63 SOUTH AMERICA MALARIA TREATMENT MARKET: BY COUNTRY (2020 & 2027) 275
  • FIGURE 64 SOUTH AMERICA MALARIA TREATMENT MARKET: BY COUNTRY (2019 & 2027) 276
  • FIGURE 65 SOUTH AMERICA MALARIA TREATMENT MARKET: BY PRODUCT TYPE (2020-2027) 276
  • FIGURE 66 EUROPE MALARIA TREATMENT MARKET: SNAPSHOT (2019) 294
  • FIGURE 67 EUROPE MALARIA TREATMENT MARKET: BY COUNTRY (2019) 296
  • FIGURE 68 EUROPE MALARIA TREATMENT MARKET: BY COUNTRY (2020 & 2027) 296
  • FIGURE 69 EUROPE MALARIA TREATMENT MARKET: BY COUNTRY (2019 & 2027) 297
  • FIGURE 70 EUROPE MALARIA TREATMENT MARKET: BY PRODUCT TYPE (2020-2027) 297
  • FIGURE 71 NORTH AMERICA MALARIA TREATMENT MARKET: SNAPSHOT (2019) 368
  • FIGURE 72 NORTH AMERICA MALARIA TREATMENT MARKET: BY COUNTRY (2019) 370
  • FIGURE 73 NORTH AMERICA MALARIA TREATMENT MARKET: BY COUNTRY (2020 & 2027) 370
  • FIGURE 74 NORTH AMERICA MALARIA TREATMENT MARKET: BY COUNTRY (2019 & 2027) 371
  • FIGURE 75 NORTH AMERICA MALARIA TREATMENT MARKET: BY TYPE (2020-2027) 371
  • FIGURE 76 GLOBAL MALARIA TREATMENT MARKET: COMPANY SHARE 2019 (%) 389
  • FIGURE 77 MIDDLE EAST & AFRICA MALARIA TREATMENT MARKET: COMPANY SHARE 2019 (%) 390
  • FIGURE 78 ASIA-PACIFIC MALARIA TREATMENT MARKETMARKET: COMPANY SHARE 2019 (%) 391
  • FIGURE 79 SOUTH AMERICA MALARIA TREATMENT MARKET: COMPANY SHARE 2019 (%) 392